A detailed history of Td Asset Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 258,158 shares of TXG stock, worth $3.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
258,158
Previous 284,564 9.28%
Holding current value
$3.95 Million
Previous $5.53 Million 5.33%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$15.71 - $23.49 $414,838 - $620,276
-26,406 Reduced 9.28%
258,158 $5.83 Million
Q2 2024

Aug 02, 2024

SELL
$19.45 - $37.37 $1.85 Million - $3.55 Million
-95,000 Reduced 25.03%
284,564 $5.53 Million
Q1 2024

May 08, 2024

BUY
$36.08 - $54.3 $3.77 Million - $5.67 Million
104,400 Added 37.94%
379,564 $14.2 Million
Q4 2023

Feb 12, 2024

BUY
$34.32 - $57.55 $1.26 Million - $2.12 Million
36,800 Added 15.44%
275,164 $15.4 Million
Q3 2023

Oct 27, 2023

BUY
$40.86 - $62.98 $4.1 Million - $6.32 Million
100,382 Added 72.75%
238,364 $9.83 Million
Q2 2023

Aug 09, 2023

SELL
$50.96 - $58.72 $323,494 - $372,754
-6,348 Reduced 4.4%
137,982 $7.7 Million
Q1 2023

May 10, 2023

BUY
$35.33 - $55.79 $1.24 Million - $1.95 Million
34,982 Added 31.99%
144,330 $8.05 Million
Q4 2022

Feb 06, 2023

SELL
$24.4 - $41.3 $509,959 - $863,169
-20,900 Reduced 16.05%
109,348 $3.98 Million
Q3 2022

Nov 07, 2022

BUY
$28.48 - $52.59 $2.05 Million - $3.79 Million
72,100 Added 123.99%
130,248 $3.9 Million
Q2 2022

Aug 04, 2022

SELL
$36.95 - $82.41 $162,025 - $361,367
-4,385 Reduced 7.01%
58,148 $2.63 Million
Q1 2022

May 10, 2022

BUY
$55.7 - $145.79 $141,366 - $370,015
2,538 Added 4.23%
62,533 $4.76 Million
Q4 2021

Feb 10, 2022

BUY
$135.05 - $182.59 $649,050 - $877,527
4,806 Added 8.71%
59,995 $8.94 Million
Q3 2021

Nov 09, 2021

BUY
$145.58 - $192.14 $4,367 - $5,764
30 Added 0.05%
55,189 $8.03 Million
Q2 2021

Aug 11, 2021

BUY
$134.22 - $202.37 $2.05 Million - $3.1 Million
15,306 Added 38.41%
55,159 $10.1 Million
Q1 2021

May 14, 2021

BUY
$140.25 - $196.86 $368,016 - $516,560
2,624 Added 7.05%
39,853 $7.21 Million
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $1.64 Million - $2.13 Million
12,990 Added 53.59%
37,229 $5.27 Million
Q3 2020

Nov 10, 2020

BUY
$87.44 - $125.0 $419,274 - $599,375
4,795 Added 24.66%
24,239 $3.02 Million
Q2 2020

Aug 13, 2020

BUY
$58.39 - $89.31 $233,560 - $357,240
4,000 Added 25.9%
19,444 $1.74 Million
Q1 2020

May 15, 2020

BUY
$51.57 - $106.62 $299,106 - $618,396
5,800 Added 60.14%
15,444 $962,000
Q4 2019

Feb 11, 2020

SELL
$46.07 - $79.54 $127,291 - $219,769
-2,763 Reduced 22.27%
9,644 $735,000
Q3 2019

Nov 07, 2019

BUY
$49.99 - $62.0 $620,225 - $769,234
12,407 New
12,407 $625,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.45B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.